The global market for cannabis-infused products is on a trajectory of accelerated expansion, with a forecast to jump from the current $33.85 billion in 2025 to an impressive $78.51 billion by 2029, according to a new report from Research and Markets released this week. The growth represents a Compound Annual Growth Rate (CAGR) of 23.4%, showcasing the transformative potential of the sector.

Medicinal Applications Lead the Growth

The study highlights that the medicinal segment is among the main drivers of this expansion. The increasing legalization of cannabis for therapeutic purposes, coupled with the rising awareness of the medicinal benefits of cannabinoids, has been fueling the demand for specialized products.

Factors contributing to this exponential growth include:

• Expansion of Medical Applications: Greater acceptance of CBD-based products for treating various conditions
• Innovations in Formulations: Development of products with precise dosages and increased bioavailability
• Investments in R&D: Growing investment in research and development of new therapies

• Channel Diversification: Expansion of specialized e-commerce platforms

   

Patient Experience

One of the key innovations highlighted in the report is the SoRSE emulsion technology, which is transforming the experience with medicinal cannabis products. Canadian company Aurora Cannabis Inc. exemplifies this trend by launching a new line of cannabis-infused beverages that utilize this patented technology.

The SoRSE technology offers significant benefits for patients:

• Higher bioavailability of cannabinoids
• Faster onset of action and more predictable effects
• Enhanced sensory experience, masking the natural bitterness of cannabis

• Precise and consistent dosing

   

E-commerce growth emerges as a crucial catalyst for market expansion. The U.S. e-commerce sector recorded sales of $289.2 billion in the first quarter of 2024, a 2.1% increase from the previous quarter, facilitating patients' access to medicinal cannabis products.

Digital platforms offer specific advantages for the medicinal sector:

• Easy access for patients with reduced mobility
• Wider variety of specialized products
• Detailed information on formulations and dosages
• Discreet and secure delivery
  
   

Moving Market

The report also points to a trend of consolidation in the sector. Organigram Holdings Inc. recently acquired Motif Labs Ltd., a move aimed at strengthening its position in the cannabis-infused products segment and expanding its capabilities for producing high-quality extracts.

Diversification of Medicinal Products

The market presents comprehensive segmentation, including:

Topical Products: CBD lotions, facial serums, and hemp moisturizers for dermatological treatments;

Edible Products: Gummies, pills, and beverages with controlled dosages;

Specialized Products: Intimate lubricants and personal care products.

Outlook for the Sector

With North America leading the market in 2024, the outlook for the coming years is promising. The convergence of progressive legalization, technological advancements, and increasing medical acceptance creates a conducive environment for the development of innovative therapeutic solutions.

For healthcare professionals and patients, this expansion represents not only greater availability of alternative treatments but also products with enhanced quality and efficacy, the result of significant investments in research and development.

The medicinal cannabis market is thus poised to establish itself as a robust and innovative segment in the global pharmaceutical industry, offering new therapeutic hopes for millions of patients worldwide.

Source: Research and Markets - Cannabis-Infused Products Market Report 2025